Symbol: ZTS Sector: Healthcare Industry: Drug Manufacturers
Update: 2019-06-10 23:40:01
Report Date |
Operating Revenue |
Total Revenue |
Cost of Revenue |
Gross Profit |
Operating Expense |
Operating Income |
Net Income |
Current Assets |
Total Assets |
Total Liabilities |
Shareholders Equity |
Current Cash |
Current Debt |
Total Cash |
Total Debt |
Cash Change |
Cash Flow |
R&D |
2019-03-31 |
1,455,000,000 |
1,455,000,000 |
518,000,000 |
937,000,000 |
509,000,000 |
428,000,000 |
312,000,000 |
4,379,000,000 |
10,883,000,000 |
8,566,000,000 |
2,317,000,000 |
1,728,000,000 |
- |
1,793,000,000 |
- |
123,000,000 |
389,000,000 |
102,000,000 |
Update: 2019-06-10 23:40:01
Report Date |
Operating Revenue |
Total Revenue |
Cost of Revenue |
Gross Profit |
Operating Expense |
Operating Income |
Net Income |
Current Assets |
Total Assets |
Total Liabilities |
Shareholders Equity |
Current Cash |
Current Debt |
Total Cash |
Total Debt |
Cash Change |
Cash Flow |
R&D |
2018-12-31 |
1,564,000,000 |
1,564,000,000 |
544,000,000 |
1,020,000,000 |
584,000,000 |
436,000,000 |
345,000,000 |
4,399,000,000 |
10,777,000,000 |
8,592,000,000 |
2,185,000,000 |
1,602,000,000 |
9,000,000 |
1,701,000,000 |
6,452,000,000 |
313,000,000 |
584,000,000 |
125,000,000 |
2018-09-30 |
1,480,000,000 |
1,480,000,000 |
473,000,000 |
1,007,000,000 |
507,000,000 |
500,000,000 |
347,000,000 |
4,076,000,000 |
10,459,000,000 |
8,341,000,000 |
2,118,000,000 |
1,286,000,000 |
- |
1,391,000,000 |
- |
-251,000,000 |
550,000,000 |
108,000,000 |
2018-06-30 |
1,415,000,000 |
1,415,000,000 |
447,000,000 |
968,000,000 |
484,000,000 |
484,000,000 |
384,000,000 |
4,239,000,000 |
8,603,000,000 |
6,621,000,000 |
1,970,000,000 |
1,558,000,000 |
- |
1,558,000,000 |
- |
-80,000,000 |
267,000,000 |
102,000,000 |
2018-03-31 |
1,366,000,000 |
1,366,000,000 |
447,000,000 |
919,000,000 |
458,000,000 |
461,000,000 |
352,000,000 |
4,267,000,000 |
8,690,000,000 |
6,715,000,000 |
1,960,000,000 |
1,654,000,000 |
- |
1,654,000,000 |
- |
82,000,000 |
389,000,000 |
97,000,000 |
Update: 2019-06-10 23:40:01
Report Date |
Operating Revenue |
Total Revenue |
Cost of Revenue |
Gross Profit |
Operating Expense |
Operating Income |
Net Income |
Current Assets |
Total Assets |
Total Liabilities |
Shareholders Equity |
Current Cash |
Current Debt |
Total Cash |
Total Debt |
Cash Change |
Cash Flow |
R&D |
2017-12-31 |
1,460,000,000 |
1,460,000,000 |
457,000,000 |
1,003,000,000 |
494,000,000 |
509,000,000 |
81,000,000 |
4,217,000,000 |
8,586,000,000 |
6,800,000,000 |
1,770,000,000 |
1,564,000,000 |
- |
1,564,000,000 |
- |
-413,000,000 |
608,000,000 |
110,000,000 |